Meta-analysis of genome-wide associations and polygenic risk prediction for atrial fibrillation in more than 180,000 cases

  • Carolina Roselli
  • , Ida Surakka
  • , Morten S Olesen
  • , Gardar Sveinbjornsson
  • , Nicholas A Marston
  • , Seung Hoan Choi
  • , Hilma Holm
  • , Mark Chaffin
  • , Daniel Gudbjartsson
  • , Matthew C Hill
  • , Hildur Aegisdottir
  • , Christine M Albert
  • , Alvaro Alonso
  • , Christopher D Anderson
  • , Dan E Arking
  • , David O Arnar
  • , John Barnard
  • , Emelia J Benjamin
  • , Eugene Braunwald
  • , Ben Brumpton
  • Archie Campbell, Nathalie Chami, Daniel I Chasman, Kelly Cho, Eue-Keun Choi, Ingrid E Christophersen, Mina K Chung, David Conen, Harry J Crijns, Michael J Cutler, Tomasz Czuba, Scott M Damrauer, Martin Dichgans, Marcus Dörr, Elton Dudink, ThuyVy Duong, Christian Erikstrup, Tõnu Esko, Diane Fatkin, Jessica D Faul, Manuel Ferreira, Daniel F Freitag, Santhi K Ganesh, J Michael Gaziano, Bastiaan Geelhoed, Jonas Ghouse, Christian Gieger, Franco Giulianini, Sarah E Graham, Vilmundur Gudnason, BioBank Japan Project, Regeneron Genetics Center, DBDS Genomic Consortium, Patrick T. Ellinor*
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Atrial fibrillation (AF) is the most common heart rhythm abnormality and is a leading cause of heart failure and stroke. This large-scale meta-analysis of genome-wide association studies increased the power to detect single-nucleotide variant associations and found more than 350 AF-associated genetic loci. We identified candidate genes related to muscle contractility, cardiac muscle development and cell-cell communication at 139 loci. Furthermore, we assayed chromatin accessibility using assay for transposase-accessible chromatin with sequencing and histone H3 lysine 4 trimethylation in stem cell-derived atrial cardiomyocytes. We observed a marked increase in chromatin accessibility for our sentinel variants and prioritized genes in atrial cardiomyocytes. Finally, a polygenic risk score (PRS) based on our updated effect estimates improved AF risk prediction compared to the CHARGE-AF clinical risk score and a previously reported PRS for AF. The doubling of known risk loci will facilitate a greater understanding of the pathways underlying AF.
Original languageEnglish
Article number11303
Pages (from-to)539-547
Number of pages9
JournalNature Genetics
Volume57
Issue number3
DOIs
Publication statusPublished - 6 Mar 2025

Fingerprint

Dive into the research topics of 'Meta-analysis of genome-wide associations and polygenic risk prediction for atrial fibrillation in more than 180,000 cases'. Together they form a unique fingerprint.

Cite this